Israel - English - Ministry of Health

unipharm ltd, israel - amlodipine as besilate; valsartan - coated tablets - valsartan 160 mg; amlodipine as besilate 10 mg - valsartan - treatment of essential hypertension. duplex is indicated for patients whose blood pressure is not adequately controlled on monotherapy.

Israel - English - Ministry of Health

unipharm ltd, israel - amlodipine as besilate; valsartan - coated tablets - valsartan 160 mg; amlodipine as besilate 5 mg - valsartan - treatment of essential hypertension. duplex is indicated for patients whose blood pressure is not adequately controlled on monotherapy.

Israel - English - Ministry of Health

unipharm ltd, israel - amlodipine as besilate; valsartan - coated tablets - valsartan 160 mg; amlodipine as besilate 5 mg - valsartan - treatment of essential hypertension. duplex is indicated for patients whose blood pressure is not adequately controlled on monotherapy.

Israel - English - Ministry of Health

unipharm ltd, israel - amlodipine as besilate; valsartan - coated tablets - valsartan 80 mg; amlodipine as besilate 5 mg - valsartan - treatment of essential hypertension. duplex is indicated for patients whose blood pressure is not adequately controlled on monotherapy.

Israel - English - Ministry of Health

unipharm ltd, israel - amlodipine as besilate; valsartan - coated tablets - valsartan 80 mg; amlodipine as besilate 5 mg - valsartan - treatment of essential hypertension. duplex is indicated for patients whose blood pressure is not adequately controlled on monotherapy.

Israel - English - Ministry of Health

unipharm ltd, israel - aripiprazole - tablets - aripiprazole 10 mg - aripiprazole - ariply is indicated for the treatment of schizophrenia, for the treatment of moderate to severe manic episodes in bipolar i disorder and for the prevention of a new manic episode in patient who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment.ariply is indicated for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (mdd). efficacy was established in two 6-week trials in adults with mdd who had an inadequate response to antidepressant therapy during the current episode.ariply is indicated for the treatment of irritability associated with autistic disorder. efficacy was established in two 8-week trials in pediatric patients (aged 6 to 17 years) with irritability associated with autistic disorder (including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods).

Israel - English - Ministry of Health

unipharm ltd, israel - aripiprazole - tablets - aripiprazole 15 mg - aripiprazole - ariply is indicated for the treatment of schizophrenia, for the treatment of moderate to severe manic episodes in bipolar i disorder and for the prevention of a new manic episode in patient who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment.ariply is indicated for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (mdd). efficacy was established in two 6-week trials in adults with mdd who had an inadequate response to antidepressant therapy during the current episode.ariply is indicated for the treatment of irritability associated with autistic disorder. efficacy was established in two 8-week trials in pediatric patients (aged 6 to 17 years) with irritability associated with autistic disorder (including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods).

Israel - English - Ministry of Health

unipharm ltd, israel - aripiprazole - tablets - aripiprazole 30 mg - aripiprazole - ariply is indicated for the treatment of schizophrenia, for the treatment of moderate to severe manic episodes in bipolar i disorder and for the prevention of a new manic episode in patient who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment

Israel - English - Ministry of Health

unipharm ltd, israel - aripiprazole - tablets - aripiprazole 5 mg - aripiprazole - ariply is indicated for the treatment of schizophrenia, for the treatment of moderate to severe manic episodes in bipolar i disorder and for the prevention of a new manic episode in patient who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment.ariply is indicated for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (mdd). efficacy was established in two 6-week trials in adults with mdd who had an inadequate response to antidepressant therapy during the current episode.ariply is indicated for the treatment of irritability associated with autistic disorder. efficacy was established in two 8-week trials in pediatric patients (aged 6 to 17 years) with irritability associated with autistic disorder (including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods).

Israel - English - Ministry of Health

unipharm ltd, israel - simvastatin - film coated tablets - simvastatin 20 mg - simvastatin - simvastatin - coronary heart disease : in patients with coronary heart disease and hypercholesterolemia simvacor is indicated to: reduce the risk of total mortality by reducing coronary death reduce the risk of non-fatal myocardial infarction reduce the risk for undergoing myocardial revascularization procedures.reduce the risk of stroke and transient ischemic attacks (tia).hyperlipidemia: simvacor is indicated as an adjunct to diet to reduce elevated total-c ldl-c apo b and tg and to increase hdl-c in patients with primary hypercholesterolemia( heterozygous familial and nonfamilial) and mixed dyslipidemia (frederickson types iia and iib) simvacor therefore lowers the ldl-c/hdl-c and the total-c/hdl-c ratios.homozygous familial hypercholesterolemia: simvacor is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol ldl-cholesterol and apolipoprotein b in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. hypertrigly